Osteonecrosis Clinical Trial
Numerous studies describing surgical treatments to preserve hip replacements has several controversies and none of these procedures are universally accepted nor have compelling evidence for osteonecrosis of the femoral head (ONFH). With developing a newly approach osteonecrotic device surgical procedure to support the regeneration of necrotic bone and articular cartilage in vivo, this will be the first randomized-controlled feasibility study to determine its safety in ONFH patients.
Total of 20 patients were enrolled and randomized in this study. There are two groups, 10 patients in osteonecrotic device group; 10 incore decompression group. After their baseline data has been collected and their surgical procedure has been completed, the following postoperative data collection are then continued to 6 weeks, 12 weeks, 6 months, one year, and two years' prior from the start of their surgery, in order to understand the new approach of the osteonecrotic device's safety in comparison to the core decompression surgical procedure. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04072055 -
MOTO Post-marketing Surveillance Study
|
||
Terminated |
NCT02941666 -
Human Mesenchymal Stem Cells in the Synovial Fluid of the Hip
|
||
Terminated |
NCT01763684 -
Oxford Signature vs. Conventional Global Study
|
N/A | |
Completed |
NCT00505219 -
Ixmyelocel-T Treatment of Patients With Osteonecrosis of the Femoral Head
|
Phase 3 | |
Withdrawn |
NCT02632903 -
Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot Study
|
Phase 2 | |
Active, not recruiting |
NCT01458782 -
ACI-C Versus AMIC. A Randomized Trial Comparing Two Methods for Repair of Cartilage Defects in the Knee
|
N/A | |
Completed |
NCT01583465 -
Efficacy of Aquamantys for Reducing Transfusions With Anterior Supine Intermuscular Approach Total Hip Arthroplasty
|
N/A | |
Active, not recruiting |
NCT04401267 -
Hypertension Intervention to Reduce Osteonecrosis in Children With Acute Lymphoblastic Leukemia/Lymphoma
|
Phase 2 | |
Completed |
NCT03197623 -
Safety and Tolerability of Intravenous LLP2A-Alendronate for Osteopenia Secondary to Glucocorticoids
|
Phase 1 | |
Active, not recruiting |
NCT05283148 -
Sickle Cell Disease (SCD) Bone Pain Study
|
N/A | |
Completed |
NCT05684588 -
Post-COVID-19 Sequelae: Osteonecrosis of Femoral Head
|
N/A | |
Terminated |
NCT03269409 -
Use of Adipose Derived Regenerative Cells in Bilateral Femoral Head Osteonecrosis
|
Phase 1 | |
Completed |
NCT00913679 -
A Comparison of Two Different Surgical Techniques in Hip Resurfacing Arthroplasty
|
N/A | |
Enrolling by invitation |
NCT02893293 -
Imaging of Osteonecrosis With Ferumoxytol-Enhanced MRI
|
Phase 4 | |
Completed |
NCT01345097 -
A Short Metaphyseal Fitting Total Hip Arthroplasty in Young and Elderly Patients
|
Phase 4 | |
Recruiting |
NCT00260897 -
Molecular Genetic Study of Avascular Necrosis of the Femoral Head
|
N/A | |
Not yet recruiting |
NCT06016634 -
Alendronate for Osteonecrosis in Adults With Sickle Cell Disease
|
Phase 2 | |
Completed |
NCT02077647 -
Focused Registry on the Conservative Treatment of Osteoarthritis of the Knee
|
||
Recruiting |
NCT01619124 -
Osteonecroses in Pediatric Patients With ALL
|
N/A | |
Completed |
NCT02458937 -
Functional Outcomes Following Hip Core Decompression in Younger Participants With Osteonecrosis
|